Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)

CUSIP: 738920107

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Common Stock
Shares outstanding
138,530,928
Total 13F shares
1,000
Share change
-4,339,851
Total reported value
$1,030
Price per share
$1.03
Number of holders
1
Value change
-$607,567
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 738920107?
CUSIP 738920107 identifies ASBP - Aspire Biopharma Holdings, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ASBP - Aspire Biopharma Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Lance Friedman
13D/G
4.5%
2,207,886
$1,037,706 -$782,315 06 May 2025
ARDSLEY ADVISORY PARTNERS LP
13D/G
7.8%
10,750,000
$860,000 $0 31 Dec 2025
UBS Group AG
13F
Company
1.8%
2,514,873
$331,963 31 Dec 2025
13F
Mint Tower Capital Management B.V.
13F
Company
class O/S missing
25,000
$132,000 31 Dec 2025
13F
Crewe Advisors LLC
13F
Company
0.59%
813,427
$107,292 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.5%
688,143
$90,766 31 Dec 2025
13F
Harraden Circle Investments, LLC
13D/G
0.31%
150,000
$70,500 $0 31 Mar 2025
VANGUARD GROUP INC
13F
Company
0.31%
428,552
$56,569 31 Dec 2025
13F
Optivise Advisory Services LLC
13F
Company
0.26%
357,340
$47,133 31 Dec 2025
13F
XTX Topco Ltd
13F
Company
0.19%
265,471
$35,016 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.18%
247,555
$32,652 31 Dec 2025
13F
Procyon Advisors, LLC
13F
Company
0.17%
232,661
$30,688 31 Dec 2025
13F
Antara Capital LP
13F
Company
mixed-class rows
410,590
mixed-class rows
$30,189 31 Dec 2025
13F
Resolute Advisors LLC
13F
Company
0.11%
155,826
$20,553 31 Dec 2025
13F
Verition Fund Management LLC
13F
Company
mixed-class rows
530,148
mixed-class rows
$19,986 31 Dec 2025
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
983,603
$19,328 31 Dec 2025
13F
LINDEN ADVISORS LP
13F
Company
class O/S missing
899,999
$17,730 31 Dec 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
class O/S missing
1,050,000
$17,325 31 Dec 2025
13F
Three Seasons Wealth, LLC
13F
Company
0.09%
125,000
$16,488 31 Dec 2025
13F
VR Advisory Services Ltd
13F
Company
mixed-class rows
197,083
mixed-class rows
$14,491 31 Dec 2025
13F
Virtu Financial LLC
13F
Company
0.08%
108,791
$14,000 31 Dec 2025
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
class O/S missing
681,516
$13,392 31 Dec 2025
13F
Sculptor Capital LP
13F
Company
class O/S missing
500,000
$9,825 31 Dec 2025
13F
PERISCOPE CAPITAL INC.
13F
Company
mixed-class rows
174,924
mixed-class rows
$8,656 31 Dec 2025
13F
EP Wealth Advisors, LLC
13F
Company
0.05%
62,685
$8,268 31 Dec 2025
13F
TORONTO DOMINION BANK
13F
Company
class O/S missing
516,445
$8,263 31 Dec 2025
13F
Donald G. Fell
3/4/5
Director
0.01%
20,000
$7,800 $0 04 Jun 2025
P SCHOENFELD ASSET MANAGEMENT LP
13F
Company
0.04%
58,563
$7,724 31 Dec 2025
13F
Avion Wealth
13F
Company
0.04%
54,113
$7,000 31 Dec 2025
13F
Scientech Research LLC
13F
Company
0.04%
51,602
$6,806 31 Dec 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.04%
49,129
$6,480 31 Dec 2025
13F
BARCLAYS PLC
13F
Company
class O/S missing
350,000
$5,775 31 Dec 2025
13F
Clear Street Group Inc.
13F
Company
class O/S missing
330,764
$5,458 31 Dec 2025
13F
VALLEY WEALTH MANAGERS, INC.
13F
Company
0.03%
40,000
$5,276 31 Dec 2025
13F
Platform Technology Partners
13F
Company
0.03%
37,611
$4,961 31 Dec 2025
13F
Crossingbridge Advisors, LLC
13F
Company
mixed-class rows
74,194
mixed-class rows
$4,034 31 Dec 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
199,999
$3,300 31 Dec 2025
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
197,144
$3,253 31 Dec 2025
13F
Athos Capital Ltd
13F
Company
class O/S missing
21,383
$3,000 31 Dec 2025
13F
Context Capital Management, LLC
13F
Company
class O/S missing
175,000
$2,888 31 Dec 2025
13F
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
138,536
$2,715 31 Dec 2025
13F
LMR Partners LLP
13F
Company
class O/S missing
125,000
$2,063 31 Dec 2025
13F
WHITEBOX ADVISORS LLC
13F
Company
class O/S missing
118,750
$1,959 31 Dec 2025
13F
StoneX Group Inc.
13F
Company
0.01%
14,675
$1,936 31 Dec 2025
13F
Point72 Asset Management, L.P.
13F
Company
0.01%
14,244
$1,879 31 Dec 2025
13F
Allred Capital Management, LLC
13F
Company
0.01%
11,185
$1,475 31 Dec 2025
13F
Fisher Asset Management, LLC
13F
Company
0.01%
10,000
$1,319 31 Dec 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
9,609
$1,267 31 Dec 2025
13F
Limestone Investment Advisors LP
13F
Company
class O/S missing
75,000
$1,238 31 Dec 2025
13F
Blue Owl Capital Holdings LP
13F
Company
class O/S missing
50,000
$1,000 31 Dec 2025
13F

Institutional Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q1 2026

As of 31 Mar 2026, Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 1,000 shares. The largest 1 holders included VALLEY WEALTH MANAGERS, INC.. This page lists 1 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
30
Q1 2026 holders
1
Holder diff
-29
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .